Unit 701-706, K11 Atelier King’s Road
728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 400
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Sheng Wu Yeung | Co-Founder, Chairperson, CEO & CEO of Insighta | N/A | N/A | 1979 |
Dr. Chi Hung Tzang Ph.D. | Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board | N/A | N/A | 1975 |
Mr. Hoi Chun Lo | Chief Financial Officer | N/A | N/A | 1985 |
Dr. Yung Ho Wong DPHIL | Chief Technology Officer | N/A | N/A | 1982 |
Ms. Yvonne L. Wong | Chief Corporate Development Officer | N/A | N/A | N/A |
Ms. Samantha Kwok | Vice President People & Culture | N/A | N/A | N/A |
Dr. Senthil Sundaram M.D. | Chief Clinical Officer | N/A | N/A | 1974 |
Mr. Avrom Boris Lasarow | Chief Executive Officer of EMEA | N/A | N/A | 1977 |
Dr. Shih-Chang Ong M.D. | Chief Medical Officer & Member of Scientific Advisory Board | N/A | N/A | 1978 |
Mr. Joel Neoh | Chief Consumer Officer & MD for CircleDNA | N/A | N/A | N/A |
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.